The Penn Center for Innovation announces two key appointments to expand and enhance institution-wide innovation and technology commercialization activities
The Penn Center for Innovation (PCI) has announced two key appointments to support the next phase of its comprehensive innovation and commercialization plan.
The program was well attended by professionals from across the globe in pharma, medtech and biotech industries and offered an incredible opportunity for networking and connection.
Last week, PCI hosted IvyTech, an annual conference that brings together technology transfer professionals to discuss the future of research, commercialization, and intellectual property.
PCI and Penn Medicine Represent at PHILLY BUILDS BIO+: 2ND ANNUAL SYMPOSIUM FOR LIFE SCIENCE INNOVATION AND DEVELOPMENT
Jon Epstein was keynote speaker and Ben Dibling served on a panel discussing science and technology in the context of accelerating innovation.
The the Penn Center for Innovation, along with Penn Engineering and Penn Medicine, presented speaker sessions with experts in the field.
Quantum Technology Innovation at Penn Engineering Receives Major Boost through Multi-Year Collaboration with Quantum Motion Technologies
Quantum Motion Technologies Ltd., a privately held company in London, UK, entered into an R&D collaboration agreement with Penn.
AlphaThera, a startup company co-founded by Andrew Tsourkas, PhD, entered into an expanded license agreement with Penn.
Qishui (Tracy) Chen, Assistant Director of Licensing, Physical Sciences, and Engineering shared and discussed a wide range of available drug delivery technologies come out of Penn.
Three staff members spoke at Track 5: “$tuff You Should Know about Starting Up and Spinning Out a Cell and Gene Biotech.”
Fang-Yen and Fouad co-founded the startup company Tau Scientific Instruments and have licensed the Penn technology.